Our analysis of PS19 tauopathy mice showed elevated, not depleted, PAS granule density at advanced stages of tau accumulation, which we note contrasts with the trajectory of human CA at comparable stages of hippocampal tau deposition. The gene discussed is MAPT; the disease is tauopathy.